Parkway Life Real Estate Investment Trust (C2PU.SI)
Full history for every metric is available with a Kvantra account
Parkway Life Real Estate Investment Trust (C2PU.SI)
No price history available.
Key financial summary
Financials in SGD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | SGD m | 121 | 121 | 130 | 147 | 145 | 165 | 155 | 167 |
| Operating profit | SGD m | 131 | 90 | ||||||
| Net profit | SGD m | 87 | 332 | 41 | 100 | 95 | 153 | 165 | 118 |
| EPS reported | SGD | 0.23 | 0.26 | ||||||
| Operating cashflow per share | SGD | 0.15 | 0.00 | ||||||
| Capex per share | SGD | 0.15 | 0.00 | ||||||
| FCF per share | SGD | 0.00 | 0.00 | ||||||
| Free cash flow | SGD m | 0 | 0 | ||||||
| Net debt | SGD m | 838 | 842 | ||||||
| Book value equity | SGD m | 1,670 | 1,677 | ||||||
| Book value per share | SGD | 2.56 | 2.57 | ||||||
| Number of shares | m | 652.65 | 652.69 | ||||||
| DPS (TTM paid) | SGD | 0.15 | 0.16 |
Financial summary
Financials in SGD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E TTM | x | 17.74 | 16.39 | ||||||
| P/B LTM | x | 1.59 | 1.59 | ||||||
| P/S LTM | x | 16.13 | 17.17 | ||||||
| P/FCF LTM | x | 0.00 | 0.00 | ||||||
| EV/EBITDA LTM | x | 26.77 | 0.00 | ||||||
| EV/Sales LTM | x | 21.22 | 22.70 | ||||||
| Earnings Yield LTM | % | +5.64% | +6.10% | ||||||
| FCF Yield | % | 0.00% | 0.00% | ||||||
| Quality | |||||||||
| ROE | % | +9.15% | +10.02% | ||||||
| ROIC | % | +4.84% | +3.34% | ||||||
| Operating margin | % | +79.29% | +58.34% | ||||||
| Gross margin | % | +81.58% | +84.19% | ||||||
| FCF/Sales | % | 0.00% | 0.00% | ||||||
| Growth and momentum | |||||||||
| EPS Growth YoY | % | +43.75% | +62.50% | ||||||
| Sales Growth YoY | % | +13.91% | +7.05% | ||||||
| Net Income Growth YoY | % | +60.76% | +73.82% | ||||||
| FCF Growth | % | -100.00% | -100.00% | ||||||
| Operating Profit Growth | % | -0.45% | -31.16% | ||||||
| Dividend and capital structure | |||||||||
| Dividend Yield | % | +2.46% | +4.00% | ||||||
| Dividend Growth | % | +2.48% | +9.99% | ||||||
| Payout Ratio | % | +43.59% | 0.00% | ||||||
| FCF/Debt | x | 0.00 | 0.00 | ||||||
| Net Debt/EBITDA | x | 6.42 | 0.00 | ||||||
| EBIT/Net interest | x | 8.93 | 0.00 | ||||||
| Net debt/market cap | % | +33.26% | +33.65% | ||||||
| Net debt/Equity | x | 0.50 | 0.50 | ||||||
| Gross debt/equity | x | 0.53 | 0.54 | ||||||
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
Company overview
Parkway Life Real Estate Investment Trust (PLife REIT) is recognized as one of Asia's foremost publicly listed healthcare REITs based on its significant asset holdings. The trust's investment strategy focuses on acquiring income-generating real estate and associated assets predominantly utilized for healthcare and related services. This comprehensive mandate covers hospitals, various medical facilities, and properties supporting healthcare research, education, and the production or warehousing of pharmaceuticals, medical goods, and devices. As of December 31, 2020, PLife REIT managed a robust and geographically diversified portfolio comprising 54 properties across the Asia Pacific region, with a total valuation of approximately S$2.02 billion. Its Singaporean assets include the largest collection of strategically located private hospitals: Mount Elizabeth Hospital, Gleneagles Hospital, and Parkway East Hospital. Furthermore, its Japanese holdings encompass 50 high-quality nursing home and care facilities situated in various prefectures. The trust also possesses strata-titled units within the MOB Specialist Clinics in Kuala Lumpur, Malaysia.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Parkway Life Real Estate Investment Trust (C2PU.SI)
No price history available.
Based on consensus from external analysts. Not Kvantra's opinion.
Parkway Life Real Estate Investment Trust (PLife REIT) is recognized as one of Asia's foremost publicly listed healthcare REITs based on its significant asset holdings. The trust's investment strategy focuses on acquiring income-generating real estate and associated assets predominantly utilized for healthcare and related services. This comprehensive mandate covers hospitals, various medical facilities, and properties supporting healthcare research, education, and the production or warehousing of pharmaceuticals, medical goods, and devices. As of December 31, 2020, PLife REIT managed a robust and geographically diversified portfolio comprising 54 properties across the Asia Pacific region, with a total valuation of approximately S$2.02 billion. Its Singaporean assets include the largest collection of strategically located private hospitals: Mount Elizabeth Hospital, Gleneagles Hospital, and Parkway East Hospital. Furthermore, its Japanese holdings encompass 50 high-quality nursing home and care facilities situated in various prefectures. The trust also possesses strata-titled units within the MOB Specialist Clinics in Kuala Lumpur, Malaysia.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free